Allelic differences in the relationship between proteasome activity and MHC class I peptide loading

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 83-89

  Benham, Adam M ^a   Grommé, Monique ^a   Neefjes, Jacques ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA B35 ANTIGEN; LACTACYSTIN; PEPTIDE; PROTEASOME; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CELL TRANSPORT; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN DETERMINATION; THERMOSTABILITY;

ALLELES; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A ANTIGENS; HLA-A3 ANTIGEN; HUMANS; ISOELECTRIC FOCUSING; MULTIENZYME COMPLEXES; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0031858602     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Germain, R. N., and Margulies D. H. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:40.
2. Townsend, A. R. M., F. M. Gotch, and J. Davey. 1985. Cytotoxic T cells recognise fragments of the influenza nucleoprotein. Cell 42:457.
3. Townsend, A., J. Bastin, K. Gould, G. Brownlee, M. Andrew, B. Coupar, D. Boyle, S. Chan, and G. Smith. 1988. Defective presentation to class I restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211.
4. Momburg, F., G. J. Hämmerling, and J. J. Neefjes. 1996. TAP peptide transporters and antigen presentation. In MHC Molecules: Expression, Assembly and Function, Ch. 3. R. G. Urban and R. M. Chicz, eds. Landes, Amsterdam, p. 35.
5. Neefjes, J. J., F. Momburg, and G. J. Hämmerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769.
6. Momburg, F., J. Roelse, J. C. Howard, G. W. Butcher, G. J. Hämmerling, and J. J. Neefjes. 1994. Selectivity of MHC-encoded peptide transporters from human, mouse and man. Nature 367:648.
7. Groettrup, M., A. Soza, U. Kuckelkom, and P.-M. Kloetzel. 1996. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol. Today 17:429.
8. Löwe, J., D. Stock, B. Jap, P. Zwickl, W. Baumeister, and R. Huber. 1995. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4Å resolution. Science 268:533.
9. Reits, E. A. J., A. M. Benham, B. Plougastel, J. J. Neefjes, and J. Trowsdale. 1997. Dynamics of proteasome distribution in living cells. EMBO J. 16:6087.
10. Seemüller, E., A. Lupas, D. Stock, J. Löwe, R. Huber, and W. Baumeister. 1995. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 288: 579.
11. Groll, M., L. Ditzel, J. Löwe, D. Stock, M. Bochtler, H. D. Bartunik, and R. Huber. 1997. Structure of 20S proteasome from yeast at 2.4Å resolution. Nature 386:463.
12. Seemüller, E., A. Lupas, and W. Baumeister. 1996. Autocatalytic processing of the 20S proteasome. Nature 382:468.
13. Nandi, D., E. Woodward, D. B. Ginsberg, and J. J. Monaco. 1997. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor β subunits. EMBO J. 16:5363.
14. Belich, M. P., R. J. Glynne, G. Senger, D. Sheer, and J. Trowsdale. 1994. Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr. Biol. 4:769.
15. Hisamatsu, H., N. Shimbara, Y. Saito, P. Kristensen, K. B. Hendil, T. Fujiwara, E. Takahashi, N. Tanahashi, T. Tamura, A. Ichihara, and K. Tanaka. 1996. Newly identified pair of proteasomal subunits regulated reciprocally by interferon-γ. J. Exp. Med. 183:1807.
16. Driscoll, J., M. G. Brown, D. Finley, and J. J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365:262.
17. Gaczynska, M., K. L. Rock, and A. L. Goldberg. 1993. γ-Interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264.
18. Fehling, H. J., W. Swat, C. Laplace, R. Kühn, K. Rajewsky, U. Müller, and H. von Boehmer. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234.
19. van Kaer, L., P. G. Ashton-Richardt, M. Eichelberger, M. Gaczynska, K. Nagashima, K. L. Rock, A. L. Goldberg, P. C. Doherty, and S. Tonegawa. 1994. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1:533.
20. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761.
21. Harding, C. V., J. France, R. Song, J. M. Farah, S. Chatterjee, M. Iqbal, and R. Siman. 1995. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J. Immunol. 155:1767.
22. Fenteany, G., R. F. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726.
23. Craig, A., M. Gaczynska, T. Akopian, C. F. Gramm, G. Fenteany, A. L. Goldberg, and K. L. Rock. 1997. Lactacystin and clastro-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272:13437.
24. Dick, L. R., A. A. Cruikshank, A. T. Destree, L. Grenier, T. A. McCormack, F. D. Melandri, S. L. Nunes, V. J. Palombella, L. A. Parent, L. Plamondon, and R. L. Stein. 1997. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem. 272:182.
25. Cerundolo, V., A. Benham, V. Braud, S. Mukherjee, K. Gould, B. Macino, J. Neefjes, and A, Townsend. 1997. The proteasome specific inhibitor lactacystin blocks presentation of CTL epitopes in human and murine cells. Eur. J. Immunol. 27:336.
26. Vinitsky, A., L. C. Antón, H. L. Snyder, M. Orlowski, J. R. Bennink, and J. W. Yewdell. 1997. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors. J. Immunol. 159:554.
27. Hochstrasser, M. 1995. Ubiquitin, proteasomes and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7:215.
28. Coux, O., K. Tanaka, and A. L. Goldberg. 19-96. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801.
29. Ahn, K., M. Erlander, D. Leturcq, P. A. Peterson, K. Früh, and Y. Yang. 1996. In vivo characterization of the proteasome regulator PA28. J. Biol. Chem. 271: 18237.
30. Groettrup, M., A. Soza, M. Eggers, L. Kuehn, T. P. Dick, H. Schild, H.-G. Rammensee, U. H. Koszinowski, and P.-M. Kloetzel. 1996. A role for the proteasome regulator PA28α in antigen presentation. Nature 381:166.
31. Dick, T. P., T. Ruppert, M. Groettrup, P.-M. Kloetzel, L. Kuehn, U. H. Koszinowski, O. Stevanovic, H. Schild, and H.-G. Rammensee. 1996. Co-ordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253.
32. Benham, A., and J. J. Neefjes. 1997. Proteasome activity limits MHC class I assembly after interferon-γ stimulation. J. Immunol. 159:5896.
33. Bogyo, M., J. S. McMaster, M. Gaczynska, D. Tortorella, A. L. Goldberg, and H. Ploegh. 1997. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog Hslv by a new class of inhibitors. Proc. Natl Acad. Sci. USA 94:6629.
34. Parham, P, C. J. Barnstable, and W. F. Bodmer. 1979. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C antigens. J. Immunol. 123: 342.
35. Hendil, K. B., P. Kristensen, and W. Uerkvitz. 1995. Human proteasomes analysed with monoclonal antibodies. Biochem. J. 305:245.
36. Grossi de Sa, M. F., C. Martins de Sa, F. Harper, O. Coux, O. Akhayat, J. K. Pal, F. Florentin, and K. Scherrer. 1989. Cytolocalization of prosomes as a function of differentiation. J. Cell Sci. 89:151.
37. Schumacher, T. N. M., M.-T. Heemels, J. J. Neefjes, W. M. Kast, C. J. Melief, and H. L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 62:563.
38. Neefjes, J. J., B. S. Breur-Vriesendorp, G. A. Van Seventer, P. Ivanyi, and H. L. Ploegh. 1986. An improved biochemical method for the analysis of HLA-class I antigens: definition of new HLA-class I subtypes. Hum. Immunol. 16:163.
39. Sidney, J., H. M. Grey, R. T. Kubo, and A. Sette. 1996. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17:261.
40. Neefjes, J. J., G. J. Hämmerling, and F. Momburg. 1993. Folding and assembly of major histocompatibility complex class I heterodimers in the endoplasmic reticulum of intact cells precedes the binding of peptide. J. Exp. Med. 178:1971.
41. Traenckner, E. B.-M., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilises a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:5433.
42. Hunt, D. H., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. Engelhard. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261.
43. Henderson, R. A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D. H. Hunt, and V. Engelhard. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264.
44. Wei, M. L., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443.
45. Bai, A., and J. Forman. 1997. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules. J. Immunol. 159:2139.
46. Neisig, A., R. Wubbolts, X. Zhang, C. Melief, and J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196.
47. Kast, W. M., R. M. P. Brandt, J. Sidney, J.-W. Drijfhout, R. T. Kudo, H. M. Grey, C. J. M. Melief, and A. Sette. 1994. Role of HLA-A motifs in identification of potential CTL epitope in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904.
48. Falk, K., O. Rötschke, M. Takiguchi, B. Grahovac, V. Gnau, S. Stevanović, G. Jung, and H.-G. Rammensee. 1994. Peptide motifs of HLA-A1, -A11, -A31 and -A33 molecules. Immunogenetics 40:238.
49. Bjorkman, P. J., and P. Parham. 1990. Structure, function and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59:253.
50. Wells, R. S., and P. Parham. 1996. HLA class I genes: structure and diversity. In HLA and MHC: Genes, Molecules and Function, Ch. 4. M. Browning and A. McMichael, eds. Bios Scientific Publishers, Oxford, U.K. p. 77.
51. Jallepalli, P., and M. Bogyo. 1997. A degrading business: the biology of proteolysis. Trends Cell. Biol. 7:333.
52. Yewdell, J. W., L. C. Anton, and J. R. Bennink. 1996. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J. Immunol 157:1823.
53. Niedermann, G., R. Grimm, E. Geier, M. Maurer, C. Realini, C. Gartmann, J. Soll, S. Omura, M. C. Rechsteiner, W. Baumeister, and K. Eichmann. 1997. Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate-immune system. J. Exp. Med. 185:209.